Related Experiment Video
Updated: Jun 11, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Harnessing computational intelligence for synthetic lethality: A roadmap from network biology to interpretable deep
Yumi Noh1, Mohamed El-Agamy Farh2, Jae Yong Ryu3
1Data Convergence Drug Research Center, Korea Research Institute of Chemical Technology, 141 Gajeong-ro, Yuseong-gu, Daejeon 34114, Republic of Korea; Department of Medicinal and Pharmaceutical Chemistry, University of Science and Technology, Daejeon 34129, Republic of Korea.
Abstract:
Synthetic lethality (SL) is an emerging therapeutic paradigm in precision oncology that enables the selective targeting of cancer cells based on their specific genetic vulnerabilities. Despite its clinical promise, the enormous combinatorial search space of gene-gene interactions poses a major challenge for experimental screening. This review provides a critical survey of computational SL discovery, moving beyond sequential descriptions to offer a comparative synthesis of architectures ranging from traditional network-based models to advanced graph transformers and knowledge graph reasoning. We address a critical gap in the field by providing evidence-based best practices for methodological evaluation, including rigorous data splitting schemes, metric selection under class imbalance, and strategies for robust negative sampling. Furthermore, we discuss the clinical implications of synthetic rescue, a compensatory phenomenon that bypasses SL-induced cell death and acts as a primary mediator of drug resistance. By integrating multi-omics data, interpretable deep learning, and synthetic rescue mechanisms, we provide a practical translational framework for prioritizing candidates that are robust to resistance mechanisms. This roadmap aims to bridge the gap between computational prediction and actionable clinical insights in precision oncology.
Insights
Synthetic lethality (SL) computational discovery faces challenges due to vast gene interactions. This review synthesizes methods and offers best practices for evaluating SL models, addressing drug resistance for precision oncology.
Area of Science:
- Oncology
- Computational Biology
- Genetics
Background:
- Synthetic lethality (SL) offers targeted cancer therapy by exploiting genetic vulnerabilities.
- Experimental screening for SL is challenging due to the vast number of gene interactions.
- Computational approaches are crucial for efficient SL discovery.
Purpose of the Study:
- To provide a comparative synthesis of computational SL discovery architectures.
- To establish evidence-based best practices for evaluating SL prediction models.
- To discuss synthetic rescue and its role in drug resistance for clinical translation.
Main Methods:
- Review and synthesis of computational SL discovery methods, including network-based models, graph transformers, and knowledge graph reasoning.
- Analysis of methodological evaluation strategies: data splitting, metric selection, and negative sampling.
- Integration of multi-omics data and interpretable deep learning for predicting SL candidates.
Main Results:
- A comparative overview of diverse computational SL discovery architectures is presented.
- Best practices for rigorous methodological evaluation are provided, addressing class imbalance and negative sampling.
- A framework for prioritizing SL candidates robust to resistance mechanisms is proposed.
Conclusions:
- Computational methods are essential for navigating the complexity of synthetic lethality discovery in precision oncology.
- Standardized evaluation and consideration of resistance mechanisms are key for clinical translation of SL therapies.
- This review offers a roadmap to bridge computational predictions with actionable clinical insights.
Related Concept Videos
Protein Networks
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
Synthetic Biology
Golden rice
Golden rice is a genetically modified...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Pharmacogenomics: Identification of New Drug Targets
